Our Focus

In alignment with our conference’s overarching goal, centered on “Improving the lives of those living with Sickle Cell Disease & Thalassaemia,” our discussions emphasise the critical need for collective action to address these conditions. Despite advancements in therapies, including gene therapies, it is essential to acknowledge persistent systemic inequities in accessing these innovations, particularly within marginalized communities.

As we gather to explore innovative approaches, our priority is to foster collaboration among patient groups, medical professionals, researchers, policymakers, and affected communities to address these challenges. Through this conference, we aim to raise awareness, enhance care accessibility, and drive transformative research initiatives, all with the ultimate goal of ensuring equitable support and an improved quality of life for all individuals impacted by these haemoglobinopathies.

Our Objectives

Join us in making a meaningful impact on the lives of those affected by Sickle Cell Disease and Thalassaemia. Partner with us to support our objectives and contribute to the advancement of equitable care and ground-breaking research initiatives. Together, we can create lasting change and improve outcomes for individuals living with haemoglobinopathies.